Cytokinetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CYTK Key Statistics
Stock Snapshot
With a market cap of 7.68B, Cytokinetics(CYTK) trades at $62.85. The stock has a price-to-earnings ratio of -9.86.
On 2025-12-19, Cytokinetics(CYTK) stock moved within a range of $62.10 to $63.70. With shares now at $62.85, the stock is trading +1.2% above its intraday low and -1.3% below the session's peak.
Trading volume for Cytokinetics(CYTK) stock has reached 605.19K, versus its average volume of 1.85M.
The stock's 52-week range extends from a low of $29.31 to a high of $69.33.
The stock's 52-week range extends from a low of $29.31 to a high of $69.33.
CYTK News
Key Points Cytokinetics is a late-stage biopharmaceutical company targeting muscle function. Its stock has gained almost 30% this year, besting the S&P 500....
Technology Why Cytokinetics CEO Is Optimistic As FDA Deadline On Aficamten Looms Licensing Cytokinetics (CYTK) is on the cusp of its first Food and Drug Adminis...
As previously reported, Goldman Sachs upgraded Cytokinetics (CYTK) to Buy from Neutral with a price target of $95, up from $55. The firm views shares as poised...
Analyst ratings
81%
of 21 ratingsMore CYTK News
Goldman Sachs upgraded Cytokinetics (CYTK) to Buy from Neutral with a $95 price target Published first on TheFly – the ultimate source for real-time, market-mo...
Cytokinetics (CYTK), Incorporated announced that MYQORZO has been approved by the China National Medical Products Administration, NMPA, for the treatment of adu...
New insider activity at Cytokinetics ( (CYTK) ) has taken place on December 16, 2025. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fun...